# Rekovelle PK Trial in Chinese Women

> **NCT04150861** · PHASE1 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 24 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Follitropin Delta

## Key facts

- **NCT ID:** NCT04150861
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-23
- **Primary completion:** 2019-11-28
- **Final completion:** 2019-12-16
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04150861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04150861, "Rekovelle PK Trial in Chinese Women". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04150861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*